^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MT-302

    i
    Other names: MT-302
    Associations

    News

    Trials
    Company:
    CREATE Medicines
    Drug class:
    TROP-2 inhibitor
    Related drugs:
    Associations

    News

    Trials
    over2years
    Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors (clinicaltrials.gov)
    P1, N=48, Recruiting, Myeloid Therapeutics | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    HER-2 negative
    |
    MT-302
    over2years
    Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors (clinicaltrials.gov)
    P1, N=48, Not yet recruiting, Myeloid Therapeutics
    New P1 trial • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    HER-2 negative
    |
    MT-302